![PDF] Nephrotic syndrome in the course of type 1 diabetes mellitus and systemic lupus erythematosus with secondary antiphospholipid syndrome – diagnostic and therapeutic problems | Semantic Scholar PDF] Nephrotic syndrome in the course of type 1 diabetes mellitus and systemic lupus erythematosus with secondary antiphospholipid syndrome – diagnostic and therapeutic problems | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/04f6a188c85641f001261e6b89bb2b76f043af6b/3-Figure1-1.png)
PDF] Nephrotic syndrome in the course of type 1 diabetes mellitus and systemic lupus erythematosus with secondary antiphospholipid syndrome – diagnostic and therapeutic problems | Semantic Scholar
![Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis | Science Advances Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis | Science Advances](https://www.science.org/cms/asset/71f8fb16-6b48-4779-97cf-f76f54c0ce44/abd7600-f1.gif)
Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis | Science Advances
![Impact of Diabetes on Risk of End Stage Renal Disease in Danish Nationwide Cohort of Newly Diagnosed Patients with Systemic Lupus Erythematosus - ACR Meeting Abstracts Impact of Diabetes on Risk of End Stage Renal Disease in Danish Nationwide Cohort of Newly Diagnosed Patients with Systemic Lupus Erythematosus - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2019/08/GTUOHVCE-698924-1-ANY-2-.jpg)
Impact of Diabetes on Risk of End Stage Renal Disease in Danish Nationwide Cohort of Newly Diagnosed Patients with Systemic Lupus Erythematosus - ACR Meeting Abstracts
![A Case of Lupus Nephritis Aggravated by Diabetic Nephropathy with a Rapid Decline in Kidney Function | Semantic Scholar A Case of Lupus Nephritis Aggravated by Diabetic Nephropathy with a Rapid Decline in Kidney Function | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ec9f182046c0833ee20f3b099527d4792d945d27/2-Figure1-1.png)
A Case of Lupus Nephritis Aggravated by Diabetic Nephropathy with a Rapid Decline in Kidney Function | Semantic Scholar
![Cells | Free Full-Text | Circulating Cell-Free mtDNA Contributes to AIM2 Inflammasome-Mediated Chronic Inflammation in Patients with Type 2 Diabetes Cells | Free Full-Text | Circulating Cell-Free mtDNA Contributes to AIM2 Inflammasome-Mediated Chronic Inflammation in Patients with Type 2 Diabetes](https://www.mdpi.com/cells/cells-08-00328/article_deploy/html/images/cells-08-00328-g001.png)
Cells | Free Full-Text | Circulating Cell-Free mtDNA Contributes to AIM2 Inflammasome-Mediated Chronic Inflammation in Patients with Type 2 Diabetes
![Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial - The Lancet Rheumatology Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/0426f833-e5a3-4a69-9301-29d86c20fa79/gr1.jpg)
Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial - The Lancet Rheumatology
![SciELO - Brasil - Type B insulin resistance syndrome: a systematic review Type B insulin resistance syndrome: a systematic review SciELO - Brasil - Type B insulin resistance syndrome: a systematic review Type B insulin resistance syndrome: a systematic review](https://minio.scielo.br/documentstore/2359-4292/cxpGgt3qpsqP95GKRjHxb9g/96881e8f9c3ba81c14e407241ee5003620c4738c.png)
SciELO - Brasil - Type B insulin resistance syndrome: a systematic review Type B insulin resistance syndrome: a systematic review
![Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial - The Lancet Rheumatology Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/9d480b80-15ae-475f-86ae-e70bcbbd0ed5/gr1.jpg)